CA2804970A1 - Composes spirocycliques - Google Patents
Composes spirocycliques Download PDFInfo
- Publication number
- CA2804970A1 CA2804970A1 CA2804970A CA2804970A CA2804970A1 CA 2804970 A1 CA2804970 A1 CA 2804970A1 CA 2804970 A CA2804970 A CA 2804970A CA 2804970 A CA2804970 A CA 2804970A CA 2804970 A1 CA2804970 A1 CA 2804970A1
- Authority
- CA
- Canada
- Prior art keywords
- c6alkyl
- group
- halogen
- equiv
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36384810P | 2010-07-13 | 2010-07-13 | |
US61/363,848 | 2010-07-13 | ||
PCT/US2011/043330 WO2012009217A1 (fr) | 2010-07-13 | 2011-07-08 | Composés spirocycliques |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2804970A1 true CA2804970A1 (fr) | 2012-01-19 |
Family
ID=45469764
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2804970A Abandoned CA2804970A1 (fr) | 2010-07-13 | 2011-07-08 | Composes spirocycliques |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP2013531037A (fr) |
AU (1) | AU2011279509A1 (fr) |
CA (1) | CA2804970A1 (fr) |
WO (1) | WO2012009217A1 (fr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5629380B2 (ja) | 2010-12-17 | 2014-11-19 | 田辺三菱製薬株式会社 | 連続芳香環式化合物 |
WO2012164071A1 (fr) * | 2011-06-02 | 2012-12-06 | Intervet International B.V. | Dérivés d'imidazole |
WO2013068328A1 (fr) * | 2011-11-07 | 2013-05-16 | Intervet International B.V. | Composés d'acide bicyclo[2.2.2]octan-1-ylcarboxylique comme inhibiteurs de la dgat-1 |
ES2690315T3 (es) | 2012-06-15 | 2018-11-20 | Mitsubishi Tanabe Pharma Corporation | Compuestos de imidazol y triazol como inhibidores de DGAT-1 |
US9550793B2 (en) | 2012-10-03 | 2017-01-24 | Advinus Therapeutics Limited | Spirocyclic compounds, compositions and medicinal applications thereof |
CN105073111A (zh) * | 2012-10-11 | 2015-11-18 | 默沙东公司 | 用作gpr120激动剂的取代的螺哌啶基化合物 |
WO2014140241A1 (fr) * | 2013-03-15 | 2014-09-18 | Intervet International B.V. | Dérivés de pyridine en tant qu'inhibiteurs de dgat-1 |
JO3517B1 (ar) | 2014-01-17 | 2020-07-05 | Novartis Ag | ان-ازاسبيرو الكان حلقي كبديل مركبات اريل-ان مغايرة وتركيبات لتثبيط نشاط shp2 |
CN105899493B (zh) | 2014-01-17 | 2019-03-29 | 诺华股份有限公司 | 用于抑制shp2活性的1-(三嗪-3-基/哒嗪-3-基)-哌(-嗪)啶衍生物及其组合物 |
US10093646B2 (en) | 2014-01-17 | 2018-10-09 | Novartis Ag | 1-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2 |
CN104945416B (zh) * | 2014-03-24 | 2017-11-17 | 中国科学院上海药物研究所 | 一类螺异噁唑啉衍生物、其制备方法及医药用途 |
US10647692B2 (en) * | 2015-03-12 | 2020-05-12 | Fmc Corporation | Heterocycle-substituted bicyclic azole pesticides |
EP3310774B1 (fr) | 2015-06-19 | 2020-04-29 | Novartis AG | Composés et compositions pour l'inhibition de l'activité de shp2 |
ES2741746T3 (es) | 2015-06-19 | 2020-02-12 | Novartis Ag | Compuestos y composiciones para inhibir la actividad de SHP2 |
EP3310771B1 (fr) | 2015-06-19 | 2020-07-22 | Novartis AG | Composés et compositions pour l'inhibition de l'activité de shp2 |
WO2017216706A1 (fr) | 2016-06-14 | 2017-12-21 | Novartis Ag | Composés et compositions pour l'inhibition de l'activité de shp2 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0720023A2 (pt) * | 2006-12-11 | 2018-09-04 | Novartis Ag | método para prevenir ou tratar isquemia do miocárdio por inibição da enzima dgat1 com um inibidor de dgat1 |
US20090099201A1 (en) * | 2007-05-22 | 2009-04-16 | David Robert Bolin | Diacylglycerol Acyltransferase Inhibitors |
-
2011
- 2011-07-08 CA CA2804970A patent/CA2804970A1/fr not_active Abandoned
- 2011-07-08 JP JP2013519720A patent/JP2013531037A/ja not_active Withdrawn
- 2011-07-08 WO PCT/US2011/043330 patent/WO2012009217A1/fr active Application Filing
- 2011-07-08 AU AU2011279509A patent/AU2011279509A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2013531037A (ja) | 2013-08-01 |
WO2012009217A1 (fr) | 2012-01-19 |
AU2011279509A1 (en) | 2013-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2804970A1 (fr) | Composes spirocycliques | |
AU2011256444B2 (en) | Spiro isoxazoline compounds as SSTR5 antagonists | |
AU2009304508A1 (en) | Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase | |
US10065945B2 (en) | Isoquinoline derivatives as MGAT2 inhibitors | |
US10414775B2 (en) | Compounds useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolic disease | |
WO2013096093A1 (fr) | Composés en tant qu'inhibiteurs de dgat-1 | |
AU2013329064A1 (en) | Substituted spiropiperidinyl compounds useful as GPR120 agonists | |
WO2011159657A1 (fr) | Dérivés hétérocycles bicycliques et procédés d'utilisation de ceux-ci | |
EP2760855B1 (fr) | Composés de cyclopropyle substitués, compositions contenant ces composés ainsi que leur utilisation pour le traitement du diabète de type 2 | |
WO2012024179A1 (fr) | Dérivés d'amide substitués en tant qu'inhibiteurs de dgat-1 | |
CA2805078A1 (fr) | Derives d'imidazole | |
US10414774B2 (en) | Compound useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolc disease | |
WO2012064569A1 (fr) | Dérivés d'imidazole | |
WO2011037771A1 (fr) | Dérivé de diarylméthylamide présentant une activité d'antagoniste des récepteurs de l'hormone de mélano-concentration | |
WO2012047772A2 (fr) | Dérivés d'imidazole | |
CA2837517A1 (fr) | Derives d'imidazole | |
WO2013068328A1 (fr) | Composés d'acide bicyclo[2.2.2]octan-1-ylcarboxylique comme inhibiteurs de la dgat-1 | |
WO2012112364A1 (fr) | Dérivés de lactame en tant qu'inhibiteurs de dgat-1 | |
EP2931718A1 (fr) | Nouveaux dérivés de pyridine -2-carboxamide, compositions contenant de tels composés et méthodes de traitement associées | |
WO2012096813A1 (fr) | Dérivés d'imidazole | |
WO2012122075A1 (fr) | Dérivés de lactame en tant qu'inhibiteurs de dgat-1 | |
US20150274664A1 (en) | Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment | |
WO2013068439A1 (fr) | Composés 4-amino-5-oxo-7,8-dihydropyrimido[5, 4 -f] [1, 4] oxazépine comme inhibiteurs de dgat1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |
Effective date: 20150708 |